nodes	percent_of_prediction	percent_of_DWPC	metapath
Mesalazine—PTGS2—osteoarthritis	0.748	1	CbGaD
Mesalazine—PPARG—leg—osteoarthritis	0.00902	0.166	CbGeAlD
Mesalazine—PPARG—forelimb—osteoarthritis	0.00895	0.165	CbGeAlD
Mesalazine—PPARG—hindlimb—osteoarthritis	0.00806	0.148	CbGeAlD
Mesalazine—PTGS2—skeletal joint—osteoarthritis	0.00603	0.111	CbGeAlD
Mesalazine—PTGS2—leg—osteoarthritis	0.00461	0.0848	CbGeAlD
Mesalazine—PTGS2—synovial membrane of synovial joint—osteoarthritis	0.00458	0.0842	CbGeAlD
Mesalazine—PTGS2—hindlimb—osteoarthritis	0.00412	0.0757	CbGeAlD
Mesalazine—PTGS2—cartilage tissue—osteoarthritis	0.00405	0.0745	CbGeAlD
Mesalazine—IKBKB—tendon—osteoarthritis	0.00218	0.0401	CbGeAlD
Mesalazine—Salicylate-sodium—PTGS2—osteoarthritis	0.00177	0.3	CrCbGaD
Mesalazine—PPARG—tendon—osteoarthritis	0.00136	0.0249	CbGeAlD
Mesalazine—Olsalazine—PTGS2—osteoarthritis	0.00121	0.206	CrCbGaD
Mesalazine—Diflunisal—PTGS2—osteoarthritis	0.00114	0.193	CrCbGaD
Mesalazine—Aminosalicylic Acid—PTGS2—osteoarthritis	0.00114	0.193	CrCbGaD
Mesalazine—PTGS1—tendon—osteoarthritis	0.000725	0.0133	CbGeAlD
Mesalazine—PTGS2—tendon—osteoarthritis	0.000693	0.0127	CbGeAlD
Mesalazine—Salicylic acid—PTGS2—osteoarthritis	0.000633	0.108	CrCbGaD
Mesalazine—CHUK—AGE/RAGE pathway—MMP9—osteoarthritis	0.000343	0.00179	CbGpPWpGaD
Mesalazine—PTGS2—Overview of nanoparticle effects—IL6—osteoarthritis	0.000341	0.00178	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—COL9A2—osteoarthritis	0.00034	0.00177	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—FMOD—osteoarthritis	0.000334	0.00174	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—COL9A1—osteoarthritis	0.00033	0.00172	CbGpPWpGaD
Mesalazine—CHUK—Leptin signaling pathway—IL1B—osteoarthritis	0.000328	0.00171	CbGpPWpGaD
Mesalazine—CHUK—Cardiac Hypertrophic Response—TGFB1—osteoarthritis	0.000327	0.0017	CbGpPWpGaD
Mesalazine—IKBKB—TNF receptor signaling pathway —TNF—osteoarthritis	0.000319	0.00166	CbGpPWpGaD
Mesalazine—IKBKB—AGE/RAGE pathway—MMP9—osteoarthritis	0.000311	0.00162	CbGpPWpGaD
Mesalazine—MPO—Selenium Micronutrient Network—IL6—osteoarthritis	0.000308	0.00161	CbGpPWpGaD
Mesalazine—CHUK—TWEAK Signaling Pathway—IL6—osteoarthritis	0.000305	0.00159	CbGpPWpGaD
Mesalazine—CHUK—Cardiac Hypertrophic Response—TNF—osteoarthritis	0.000305	0.00159	CbGpPWpGaD
Mesalazine—CHUK—Cytokine Signaling in Immune system—IL1RN—osteoarthritis	0.000305	0.00159	CbGpPWpGaD
Mesalazine—CHUK—Integrated Breast Cancer Pathway—MMP1—osteoarthritis	0.000304	0.00158	CbGpPWpGaD
Mesalazine—IKBKB—MAPK Signaling Pathway—IL1A—osteoarthritis	0.000299	0.00156	CbGpPWpGaD
Mesalazine—IKBKB—Leptin signaling pathway—IL1B—osteoarthritis	0.000297	0.00155	CbGpPWpGaD
Mesalazine—IKBKB—Cardiac Hypertrophic Response—TGFB1—osteoarthritis	0.000296	0.00155	CbGpPWpGaD
Mesalazine—PPARG—Adipogenesis—IGF1—osteoarthritis	0.000292	0.00152	CbGpPWpGaD
Mesalazine—ALOX5—Selenium Micronutrient Network—IL6—osteoarthritis	0.000291	0.00152	CbGpPWpGaD
Mesalazine—CHUK—TCR Signaling Pathway—IL1B—osteoarthritis	0.000283	0.00148	CbGpPWpGaD
Mesalazine—CHUK—Integrated Breast Cancer Pathway—ESR1—osteoarthritis	0.000281	0.00146	CbGpPWpGaD
Mesalazine—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—osteoarthritis	0.00028	0.00146	CbGpPWpGaD
Mesalazine—CHUK—Signaling by ERBB4—ESR1—osteoarthritis	0.000279	0.00146	CbGpPWpGaD
Mesalazine—IKBKB—TWEAK Signaling Pathway—IL6—osteoarthritis	0.000277	0.00144	CbGpPWpGaD
Mesalazine—IKBKB—Cardiac Hypertrophic Response—TNF—osteoarthritis	0.000277	0.00144	CbGpPWpGaD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—IL1RN—osteoarthritis	0.000276	0.00144	CbGpPWpGaD
Mesalazine—PTGS2—Selenium Micronutrient Network—CRP—osteoarthritis	0.000274	0.00143	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—PTGES—osteoarthritis	0.000272	0.00142	CbGpPWpGaD
Mesalazine—PPARG—Signaling events mediated by HDAC Class I—TNF—osteoarthritis	0.000268	0.0014	CbGpPWpGaD
Mesalazine—CHUK—Toll-like Receptor Signaling Pathway—CXCL8—osteoarthritis	0.000267	0.00139	CbGpPWpGaD
Mesalazine—PPARG—Transcriptional regulation of white adipocyte differentiation—TGFB1—osteoarthritis	0.000266	0.00139	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.000265	0.00138	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—IL1A—osteoarthritis	0.000259	0.00135	CbGpPWpGaD
Mesalazine—IKBKB—TCR Signaling Pathway—IL1B—osteoarthritis	0.000257	0.00134	CbGpPWpGaD
Mesalazine—CHUK—Toll-like Receptor Signaling Pathway—IL1B—osteoarthritis	0.000256	0.00134	CbGpPWpGaD
Mesalazine—PPARG—Circadian rythm related genes—LEP—osteoarthritis	0.000249	0.0013	CbGpPWpGaD
Mesalazine—PPARG—Transcriptional regulation of white adipocyte differentiation—TNF—osteoarthritis	0.000248	0.0013	CbGpPWpGaD
Mesalazine—CHUK—Signaling by Interleukins—IL1B—osteoarthritis	0.000245	0.00128	CbGpPWpGaD
Mesalazine—IKBKB—Toll-like Receptor Signaling Pathway—CXCL8—osteoarthritis	0.000242	0.00126	CbGpPWpGaD
Mesalazine—CHUK—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—osteoarthritis	0.000233	0.00121	CbGpPWpGaD
Mesalazine—IKBKB—Toll-like Receptor Signaling Pathway—IL1B—osteoarthritis	0.000233	0.00121	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—ESR1—osteoarthritis	0.000233	0.00121	CbGpPWpGaD
Mesalazine—CHUK—Disease—FMOD—osteoarthritis	0.000232	0.00121	CbGpPWpGaD
Mesalazine—PTGS1—Selenium Micronutrient Network—PTGS2—osteoarthritis	0.000231	0.00121	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by Interleukins—IL1B—osteoarthritis	0.000222	0.00116	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—CTSK—osteoarthritis	0.000221	0.00115	CbGpPWpGaD
Mesalazine—CHUK—TCR Signaling Pathway—TGFB1—osteoarthritis	0.00022	0.00115	CbGpPWpGaD
Mesalazine—CHUK—Cytokine Signaling in Immune system—IL1A—osteoarthritis	0.000219	0.00114	CbGpPWpGaD
Mesalazine—CHUK—MicroRNAs in cardiomyocyte hypertrophy—TNF—osteoarthritis	0.000217	0.00113	CbGpPWpGaD
Mesalazine—CHUK—Apoptosis—TNF—osteoarthritis	0.000217	0.00113	CbGpPWpGaD
Mesalazine—PTGS1—Selenium Micronutrient Network—IL1B—osteoarthritis	0.000215	0.00112	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—LEP—osteoarthritis	0.000212	0.00111	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—CTSK—osteoarthritis	0.000212	0.00111	CbGpPWpGaD
Mesalazine—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—osteoarthritis	0.000211	0.0011	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.00021	0.0011	CbGpPWpGaD
Mesalazine—CHUK—Regulation of toll-like receptor signaling pathway—CXCL8—osteoarthritis	0.000209	0.00109	CbGpPWpGaD
Mesalazine—PTGS2—Aryl Hydrocarbon Receptor—TNF—osteoarthritis	0.000208	0.00109	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—FMOD—osteoarthritis	0.000207	0.00108	CbGpPWpGaD
Mesalazine—CHUK—Disease—IHH—osteoarthritis	0.000207	0.00108	CbGpPWpGaD
Mesalazine—CHUK—TNF alpha Signaling Pathway—TNF—osteoarthritis	0.000202	0.00105	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—IGF1—osteoarthritis	0.000201	0.00105	CbGpPWpGaD
Mesalazine—CHUK—Regulation of toll-like receptor signaling pathway—IL1B—osteoarthritis	0.0002	0.00104	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—CTSK—osteoarthritis	0.0002	0.00104	CbGpPWpGaD
Mesalazine—IKBKB—TCR Signaling Pathway—TGFB1—osteoarthritis	0.0002	0.00104	CbGpPWpGaD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—IL1A—osteoarthritis	0.000199	0.00104	CbGpPWpGaD
Mesalazine—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—TNF—osteoarthritis	0.000197	0.00103	CbGpPWpGaD
Mesalazine—IKBKB—Apoptosis—TNF—osteoarthritis	0.000197	0.00103	CbGpPWpGaD
Mesalazine—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—osteoarthritis	0.000195	0.00102	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—CTSK—osteoarthritis	0.000192	0.001	CbGpPWpGaD
Mesalazine—CHUK—TRAF6 Mediated Induction of proinflammatory cytokines—IL6—osteoarthritis	0.000192	0.001	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—GSTO1—osteoarthritis	0.000192	0.001	CbGpPWpGaD
Mesalazine—IKBKB—Regulation of toll-like receptor signaling pathway—CXCL8—osteoarthritis	0.000189	0.000987	CbGpPWpGaD
Mesalazine—CHUK—Signaling by SCF-KIT—MMP9—osteoarthritis	0.000187	0.000974	CbGpPWpGaD
Mesalazine—CHUK—Toll-like Receptor Signaling Pathway—TNF—osteoarthritis	0.000186	0.000971	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—BGN—osteoarthritis	0.000186	0.000969	CbGpPWpGaD
Mesalazine—IKBKB—TNF alpha Signaling Pathway—TNF—osteoarthritis	0.000183	0.000956	CbGpPWpGaD
Mesalazine—IKBKB—Regulation of toll-like receptor signaling pathway—IL1B—osteoarthritis	0.000182	0.000947	CbGpPWpGaD
Mesalazine—PPARG—Adipogenesis—TGFB1—osteoarthritis	0.000175	0.000912	CbGpPWpGaD
Mesalazine—IKBKB—TRAF6 Mediated Induction of proinflammatory cytokines—IL6—osteoarthritis	0.000174	0.000909	CbGpPWpGaD
Mesalazine—CHUK—MyD88 cascade initiated on plasma membrane—IL6—osteoarthritis	0.000174	0.000907	CbGpPWpGaD
Mesalazine—CHUK—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—osteoarthritis	0.000172	0.000898	CbGpPWpGaD
Mesalazine—PTGS2—Selenium Micronutrient Network—IL1B—osteoarthritis	0.000171	0.000892	CbGpPWpGaD
Mesalazine—CHUK—MyD88 dependent cascade initiated on endosome—IL6—osteoarthritis	0.000169	0.000882	CbGpPWpGaD
Mesalazine—IKBKB—Toll-like Receptor Signaling Pathway—TNF—osteoarthritis	0.000169	0.00088	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—HSPA5—osteoarthritis	0.000169	0.000879	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—PTGES—osteoarthritis	0.000169	0.000879	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—PTGS2—osteoarthritis	0.000167	0.000871	CbGpPWpGaD
Mesalazine—CHUK—TCR Signaling Pathway—IL6—osteoarthritis	0.000166	0.000866	CbGpPWpGaD
Mesalazine—PPARG—Adipogenesis—TNF—osteoarthritis	0.000163	0.000852	CbGpPWpGaD
Mesalazine—CHUK—TNF alpha Signaling Pathway—IL6—osteoarthritis	0.000163	0.000851	CbGpPWpGaD
Mesalazine—CHUK—Toll Like Receptor 9 (TLR9) Cascade—IL6—osteoarthritis	0.000163	0.000851	CbGpPWpGaD
Mesalazine—CHUK—MyD88:Mal cascade initiated on plasma membrane—IL6—osteoarthritis	0.00016	0.000836	CbGpPWpGaD
Mesalazine—IKBKB—MyD88 cascade initiated on plasma membrane—IL6—osteoarthritis	0.000158	0.000822	CbGpPWpGaD
Mesalazine—PTGS1—Selenium Micronutrient Network—TNF—osteoarthritis	0.000156	0.000815	CbGpPWpGaD
Mesalazine—IKBKB—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—osteoarthritis	0.000156	0.000814	CbGpPWpGaD
Mesalazine—IKBKB—MAPK Signaling Pathway—IL1B—osteoarthritis	0.000156	0.000814	CbGpPWpGaD
Mesalazine—CHUK—Disease—TGFBI—osteoarthritis	0.000154	0.000803	CbGpPWpGaD
Mesalazine—CHUK—MyD88-independent cascade—IL6—osteoarthritis	0.000154	0.000802	CbGpPWpGaD
Mesalazine—IKBKB—MyD88 dependent cascade initiated on endosome—IL6—osteoarthritis	0.000153	0.0008	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—HSPA5—osteoarthritis	0.000153	0.000797	CbGpPWpGaD
Mesalazine—PPARG—Generic Transcription Pathway—SMAD3—osteoarthritis	0.000151	0.000787	CbGpPWpGaD
Mesalazine—IKBKB—TCR Signaling Pathway—IL6—osteoarthritis	0.000151	0.000785	CbGpPWpGaD
Mesalazine—CHUK—Toll-like Receptor Signaling Pathway—IL6—osteoarthritis	0.00015	0.000784	CbGpPWpGaD
Mesalazine—IKBKB—TNF alpha Signaling Pathway—IL6—osteoarthritis	0.000148	0.000772	CbGpPWpGaD
Mesalazine—IKBKB—Toll Like Receptor 9 (TLR9) Cascade—IL6—osteoarthritis	0.000148	0.000772	CbGpPWpGaD
Mesalazine—IKBKB—MyD88:Mal cascade initiated on plasma membrane—IL6—osteoarthritis	0.000145	0.000758	CbGpPWpGaD
Mesalazine—CHUK—Regulation of toll-like receptor signaling pathway—TNF—osteoarthritis	0.000145	0.000758	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—FMOD—osteoarthritis	0.000145	0.000756	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—IHH—osteoarthritis	0.000145	0.000755	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—MCF2L—osteoarthritis	0.000145	0.000755	CbGpPWpGaD
Mesalazine—CHUK—Signaling by Interleukins—IL6—osteoarthritis	0.000143	0.000749	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—SMAD3—osteoarthritis	0.000142	0.00074	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—CXCL8—osteoarthritis	0.000141	0.000735	CbGpPWpGaD
Mesalazine—IKBKB—MyD88-independent cascade—IL6—osteoarthritis	0.000139	0.000728	CbGpPWpGaD
Mesalazine—CHUK—Activated TLR4 signalling—IL6—osteoarthritis	0.000138	0.000722	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—osteoarthritis	0.000138	0.000719	CbGpPWpGaD
Mesalazine—PTGS2—Disease—FMOD—osteoarthritis	0.000137	0.000716	CbGpPWpGaD
Mesalazine—IKBKB—Toll-like Receptor Signaling Pathway—IL6—osteoarthritis	0.000136	0.00071	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—IL1B—osteoarthritis	0.000135	0.000705	CbGpPWpGaD
Mesalazine—CHUK—Disease—GSTO1—osteoarthritis	0.000133	0.000694	CbGpPWpGaD
Mesalazine—PPARG—Adipogenesis—IL6—osteoarthritis	0.000132	0.000687	CbGpPWpGaD
Mesalazine—IKBKB—Regulation of toll-like receptor signaling pathway—TNF—osteoarthritis	0.000132	0.000687	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—IHH—osteoarthritis	0.000131	0.000684	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—MCF2L—osteoarthritis	0.000131	0.000684	CbGpPWpGaD
Mesalazine—CHUK—Toll Like Receptor 4 (TLR4) Cascade—IL6—osteoarthritis	0.00013	0.000679	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by Interleukins—IL6—osteoarthritis	0.00013	0.000679	CbGpPWpGaD
Mesalazine—CHUK—Disease—BGN—osteoarthritis	0.000129	0.000673	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CAMK2B—osteoarthritis	0.000128	0.00067	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CTSK—osteoarthritis	0.000128	0.00067	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—MMP9—osteoarthritis	0.000127	0.000665	CbGpPWpGaD
Mesalazine—PTGS1—Selenium Micronutrient Network—IL6—osteoarthritis	0.000126	0.000658	CbGpPWpGaD
Mesalazine—IKBKB—Activated TLR4 signalling—IL6—osteoarthritis	0.000125	0.000655	CbGpPWpGaD
Mesalazine—PTGS2—Selenium Micronutrient Network—TNF—osteoarthritis	0.000124	0.000647	CbGpPWpGaD
Mesalazine—PPARG—Generic Transcription Pathway—ESR1—osteoarthritis	0.000123	0.000642	CbGpPWpGaD
Mesalazine—PTGS2—Disease—IHH—osteoarthritis	0.000122	0.000638	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—LEP—osteoarthritis	0.000121	0.000633	CbGpPWpGaD
Mesalazine—IKBKB—MAPK Signaling Pathway—TGFB1—osteoarthritis	0.000121	0.000633	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—TGFB1—osteoarthritis	0.000121	0.00063	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	0.00012	0.000626	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—osteoarthritis	0.000119	0.000622	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—GSTO1—osteoarthritis	0.000119	0.000619	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—PTGES—osteoarthritis	0.000118	0.000616	CbGpPWpGaD
Mesalazine—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—IL6—osteoarthritis	0.000118	0.000616	CbGpPWpGaD
Mesalazine—CHUK—Regulation of toll-like receptor signaling pathway—IL6—osteoarthritis	0.000117	0.000612	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CTSK—osteoarthritis	0.000117	0.000608	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CAMK2B—osteoarthritis	0.000117	0.000608	CbGpPWpGaD
Mesalazine—CHUK—Toll-Like Receptors Cascades—IL6—osteoarthritis	0.000116	0.000605	CbGpPWpGaD
Mesalazine—CHUK—Signaling by SCF-KIT—IL6—osteoarthritis	0.000116	0.000605	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—BGN—osteoarthritis	0.000115	0.0006	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—FMOD—osteoarthritis	0.000115	0.0006	CbGpPWpGaD
Mesalazine—CHUK—Cytokine Signaling in Immune system—IL1B—osteoarthritis	0.000114	0.000597	CbGpPWpGaD
Mesalazine—IKBKB—MAPK Signaling Pathway—TNF—osteoarthritis	0.000113	0.000591	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—TNF—osteoarthritis	0.000113	0.000588	CbGpPWpGaD
Mesalazine—CHUK—Downstream signaling of activated FGFR—IL6—osteoarthritis	0.000111	0.000579	CbGpPWpGaD
Mesalazine—CHUK—Signaling by ERBB4—IL6—osteoarthritis	0.000109	0.000569	CbGpPWpGaD
Mesalazine—IKBKB—Regulation of toll-like receptor signaling pathway—IL6—osteoarthritis	0.000106	0.000555	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—COL9A2—osteoarthritis	0.000106	0.000554	CbGpPWpGaD
Mesalazine—IKBKB—Toll-Like Receptors Cascades—IL6—osteoarthritis	0.000105	0.000548	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—TGFB1—osteoarthritis	0.000105	0.000548	CbGpPWpGaD
Mesalazine—CHUK—Downstream signal transduction—IL6—osteoarthritis	0.000104	0.000544	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR—IL6—osteoarthritis	0.000104	0.000541	CbGpPWpGaD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—IL1B—osteoarthritis	0.000104	0.000541	CbGpPWpGaD
Mesalazine—CHUK—Signaling by ERBB2—IL6—osteoarthritis	0.000103	0.000539	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—COL9A1—osteoarthritis	0.000103	0.000538	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—CRP—osteoarthritis	0.000103	0.000536	CbGpPWpGaD
Mesalazine—CHUK—DAP12 signaling—IL6—osteoarthritis	0.000103	0.000536	CbGpPWpGaD
Mesalazine—CHUK—Immune System—HSPA5—osteoarthritis	0.000102	0.000533	CbGpPWpGaD
Mesalazine—PTGS2—Selenium Micronutrient Network—IL6—osteoarthritis	0.0001	0.000522	CbGpPWpGaD
Mesalazine—CHUK—Immune System—IL1RN—osteoarthritis	9.95e-05	0.000519	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—TNF—osteoarthritis	9.81e-05	0.000512	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—MMP2—osteoarthritis	9.7e-05	0.000506	CbGpPWpGaD
Mesalazine—CHUK—DAP12 interactions—IL6—osteoarthritis	9.66e-05	0.000504	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR in disease—IL6—osteoarthritis	9.66e-05	0.000504	CbGpPWpGaD
Mesalazine—CHUK—Fc epsilon receptor (FCERI) signaling—IL6—osteoarthritis	9.66e-05	0.000504	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—COL9A2—osteoarthritis	9.63e-05	0.000502	CbGpPWpGaD
Mesalazine—CHUK—Signaling by EGFR—IL6—osteoarthritis	9.58e-05	0.0005	CbGpPWpGaD
Mesalazine—CHUK—Signaling by EGFR in Cancer—IL6—osteoarthritis	9.49e-05	0.000495	CbGpPWpGaD
Mesalazine—CHUK—Signaling by PDGF—IL6—osteoarthritis	9.45e-05	0.000493	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—PTGES—osteoarthritis	9.37e-05	0.000489	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—COL9A1—osteoarthritis	9.35e-05	0.000488	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—CRP—osteoarthritis	9.32e-05	0.000486	CbGpPWpGaD
Mesalazine—PPARG—Circadian rythm related genes—IL6—osteoarthritis	9.3e-05	0.000485	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—HSPA5—osteoarthritis	9.27e-05	0.000484	CbGpPWpGaD
Mesalazine—PTGS2—Disease—TGFBI—osteoarthritis	9.12e-05	0.000476	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—IL1RN—osteoarthritis	9.02e-05	0.000471	CbGpPWpGaD
Mesalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—IL6—osteoarthritis	8.76e-05	0.000457	CbGpPWpGaD
Mesalazine—CHUK—NGF signalling via TRKA from the plasma membrane—IL6—osteoarthritis	8.56e-05	0.000447	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—GSTO1—osteoarthritis	8.32e-05	0.000434	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—BGN—osteoarthritis	8.06e-05	0.00042	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—IL6—osteoarthritis	7.92e-05	0.000413	CbGpPWpGaD
Mesalazine—PTGS2—Disease—GSTO1—osteoarthritis	7.88e-05	0.000411	CbGpPWpGaD
Mesalazine—PTGS2—Disease—BGN—osteoarthritis	7.64e-05	0.000398	CbGpPWpGaD
Mesalazine—PPARG—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	7.42e-05	0.000387	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—MMP9—osteoarthritis	7.29e-05	0.00038	CbGpPWpGaD
Mesalazine—PPARG—Gene Expression—SMAD3—osteoarthritis	7.26e-05	0.000379	CbGpPWpGaD
Mesalazine—CHUK—Immune System—IL1A—osteoarthritis	7.16e-05	0.000374	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—osteoarthritis	7.15e-05	0.000373	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—BMP2—osteoarthritis	7.06e-05	0.000369	CbGpPWpGaD
Mesalazine—CHUK—Cytokine Signaling in Immune system—IL6—osteoarthritis	6.7e-05	0.000349	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—osteoarthritis	6.67e-05	0.000348	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—GSTO1—osteoarthritis	6.6e-05	0.000344	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—IL6—osteoarthritis	6.58e-05	0.000343	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—IL1A—osteoarthritis	6.49e-05	0.000339	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—BMP2—osteoarthritis	6.41e-05	0.000334	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—BGN—osteoarthritis	6.4e-05	0.000334	CbGpPWpGaD
Mesalazine—CHUK—Disease—SMAD3—osteoarthritis	6.33e-05	0.00033	CbGpPWpGaD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—IL6—osteoarthritis	6.07e-05	0.000317	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—TGFB1—osteoarthritis	6.01e-05	0.000314	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CRP—osteoarthritis	5.99e-05	0.000312	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—IL6—osteoarthritis	5.97e-05	0.000311	CbGpPWpGaD
Mesalazine—PPARG—Gene Expression—ESR1—osteoarthritis	5.92e-05	0.000309	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—TNF—osteoarthritis	5.61e-05	0.000293	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CRP—osteoarthritis	5.43e-05	0.000283	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—PTGS2—osteoarthritis	5.34e-05	0.000279	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	5.2e-05	0.000271	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—MMP3—osteoarthritis	4.9e-05	0.000255	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—IL6—osteoarthritis	4.53e-05	0.000236	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—MMP3—osteoarthritis	4.44e-05	0.000232	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—SMAD3—osteoarthritis	4.43e-05	0.000231	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—SMAD3—osteoarthritis	4.02e-05	0.00021	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—LEP—osteoarthritis	3.79e-05	0.000198	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—IL6—osteoarthritis	3.75e-05	0.000196	CbGpPWpGaD
Mesalazine—PTGS2—Disease—SMAD3—osteoarthritis	3.75e-05	0.000196	CbGpPWpGaD
Mesalazine—CHUK—Immune System—IL1B—osteoarthritis	3.73e-05	0.000195	CbGpPWpGaD
Mesalazine—CHUK—Disease—PTGS2—osteoarthritis	3.71e-05	0.000193	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—ESR1—osteoarthritis	3.62e-05	0.000189	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—FN1—osteoarthritis	3.57e-05	0.000186	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—LEP—osteoarthritis	3.43e-05	0.000179	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—IL6—osteoarthritis	3.4e-05	0.000178	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—IL1B—osteoarthritis	3.39e-05	0.000177	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—PTGS2—osteoarthritis	3.31e-05	0.000172	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—ESR1—osteoarthritis	3.28e-05	0.000171	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—FN1—osteoarthritis	3.24e-05	0.000169	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—IGF1—osteoarthritis	3.13e-05	0.000163	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—IGF1—osteoarthritis	2.84e-05	0.000148	CbGpPWpGaD
Mesalazine—CHUK—Disease—TGFB1—osteoarthritis	2.68e-05	0.00014	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CXCL8—osteoarthritis	2.52e-05	0.000131	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—PTGS2—osteoarthritis	2.32e-05	0.000121	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CXCL8—osteoarthritis	2.28e-05	0.000119	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—MMP9—osteoarthritis	2.28e-05	0.000119	CbGpPWpGaD
Mesalazine—CHUK—Immune System—IL6—osteoarthritis	2.19e-05	0.000114	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—MMP9—osteoarthritis	2.06e-05	0.000108	CbGpPWpGaD
Mesalazine—CHUK—Disease—IL6—osteoarthritis	2.02e-05	0.000105	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—IL6—osteoarthritis	1.98e-05	0.000103	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—TGFB1—osteoarthritis	1.88e-05	9.79e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—TGFB1—osteoarthritis	1.7e-05	8.88e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—TGFB1—osteoarthritis	1.59e-05	8.28e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—IL6—osteoarthritis	1.41e-05	7.38e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—IL6—osteoarthritis	1.28e-05	6.69e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—IL6—osteoarthritis	1.2e-05	6.24e-05	CbGpPWpGaD
